Caxton Associates LP Abb Vie Inc. Transaction History

Caxton Associates LP

$2.65 Billion
Q3 2024

A detailed history of Caxton Associates LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Caxton Associates LP holds 14,354 shares of ABBV stock, worth $2.58 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

14,354

Previous 10,213 40.55%

Holding current value

$2.58 Million

Previous $1.75 Million 61.85%

% of portfolio

0.11%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $678,461 - $825,425	4,141 Added 40.55%	14,354 $2.83 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $2.08 Million - $2.43 Million	-13,425 Reduced 56.79%	10,213 $1.75 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $696,815 - $793,956	-4,360 Reduced 15.57%	23,638 $4.3 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $1.44 Million - $1.62 Million	10,466 Added 59.7%	27,998 $4.34 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $36,870 - $42,683	276 Added 1.6%	17,532 $2.61 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $2.29 Million - $2.85 Million	17,256 New	17,256 $2.32 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $376,056 - $431,311	2,802 New	2,802 $376,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $472,505 - $554,565	-5,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $403,535 - $539,990	5,500 New	5,500 $540,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $421,765 - $639,448	-6,539 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $471,658 - $590,144	6,539 New	6,539 $571,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $1.01 Million - $1.21 Million	-16,010 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $1.05 Million - $1.34 Million	16,010 New	16,010 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $224,752 - $277,180	-2,887 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $530,792 - $590,074	-5,970 Reduced 67.4%	2,887 $273,000
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $29,806 - $35,268	-332 Reduced 3.61%	8,857 $821,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $845,479 - $1.13 Million	9,189 New	9,189 $870,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account

Caxton Associates LP Abb Vie Inc. Transaction History